The assessment of in vitro cardiotoxic potentials for synthetic cannabinoid, AM-2201

References (10)

1. Aksel G, Oner Bozan O, Kayacı M, Guneysel O, Sezgin SB, (2015). Rising threat; bonsai. Turk J Emerg Med 15: 75-78.
2. Almada M, Costa L, Fonseca BM, Amaral C, Teixeirab N, Correia-da Silva G, (2017). The synthetic cannabinoid WIN-55,212 induced-apoptosis in cytotrophoblasts cells by a mechanism dependent on CB1 receptor. Toxicol 385: 67-73.
3. Atik SU, Dedeoğlu R, Varol F, Çam H, Eroğlu AG, Saltık L, (2015). Cardiovascular side effects related with use of synthetic cannabinoids “bonzai”: two case reports. Turk Pediatri Ars 50(1): 61-64. Castellanos D and Gralnik LM, (2016). Synthetic cannabinoids 2015: an update for pediatricians in clinical practice. World J Clin Pediatr 5: 16-24.
4. Castaneto MS, Gorelick DA, Desrosiers NA, Hartman RL, Pirard S, Huestis MA, (2014). Synthetic cannabinoids: epidemiology, pharmacodynamics and clinical implications. Drug Alcohol Depen 144: 12-41. Cooper ZD, (2016). Adverse effects of synthetic cannabinoids: management of acute toxicity and withdrawal. Curr Psychiatry Rep 18(5): 52-71.
5. Couceiro J, Bandarra S, Sultan H, Bell S, Constantino S, Quintas A, (2016). Toxicological impact of JWH-018 and its phase I metabolite N-(3-hydroxypentyl) on human cell lines. Forensic Sci Int 264: 100-105. Debruyne D and Boisselier RL, (2015). Emerging drugs of abuse: current perspectives on synthetic cannabinoids. Subst Abuse Rehabil 6: 113-129.
6. Mitou G, Budak H, Gozuacik D, (2009). Techniques to study autophagy in plants. Int J Plant Genom 2015, Article ID 451357: 1-14. Gözüaçık D, (2011). Otofaji analiz yöntemleri ve uygulama aşamaları. In S. Koçtürk & H. S. Vatansever, eds. Hücre Ölümü Araştırma Teknikleri. İzmir: Dokuz Eylul University Press, 129-141.
7. Hess C, Schoeder CT, Pillaiyar T, Madea B, Müller CE, (2016). Pharmacological evaluation of synthetic cannabinoids identified as constituents of spice. Forensic Toxicol 34: 329-343.
8. Ibrahim S, Al-Saffar F, Wannenburg T, (2014). A unique case of cardiac arrest following K2 abuse. Case Reports in Cardiology 2014, Article ID 120607: 1-3.
9. McKeever RG, Vearrier D, Jacobs D, LaSala GL, Okaneku J, Greenberg MI, (2015). K2-not the spice of life; synthetic cannabinoids and ST elevation myocardial infarction: A case report. J Med Toxicol 11: 129-131.
10. Rajesh M, Mukhopadhyay P, Haskó G, Liaudet L, Mackie K, Pacher P, (2010). Cannabinoid-1 receptor activation induces reactive oxygen species-dependent and -independent mitogen-activated protein kinase activation and cell death in human coronary artery endothelial c